Matthew D. Linnik
2006
In 2006, Matthew D. Linnik earned a total compensation of $950K as Chief Scientific Officer and Executive Vice President at La Jolla Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $52,390 |
|---|---|
| Option Awards | $524,843 |
| Salary | $305,482 |
| Stock Awards | $67,333 |
| Total | $950,048 |
Linnik received $524.8K in option awards, accounting for 55% of the total pay in 2006.
Linnik also received $52.4K in non-equity incentive plan, $305.5K in salary and $67.3K in stock awards.
Rankings
In 2006, Matthew D. Linnik's compensation ranked 3,197th out of 7,022 executives tracked by ExecPay. In other words, Linnik earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,197 out of 7,022 | 55th |
Division Manufacturing | 1,009 out of 2,413 | 58th |
Major group Chemicals And Allied Products | 225 out of 673 | 67th |
Industry group Drugs | 139 out of 518 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 25 out of 112 | 78th |
Source: SEC filing on April 13, 2007.
Linnik's colleagues
We found eight more compensation records of executives who worked with Matthew D. Linnik at La Jolla Pharmaceutical in 2006.
2006
Steven Engle
La Jolla Pharmaceutical
Chief Executive Officer
2006
Deirdre Gillespie
La Jolla Pharmaceutical
Chief Executive Officer
2006
Bruce Bennett
La Jolla Pharmaceutical
Former Vice President of Manufacturing
2006
Gail Sloan
La Jolla Pharmaceutical
Secretary
2006
Paul Jenn
La Jolla Pharmaceutical
Vice President of Product Development
2006
Theodora Reilly
La Jolla Pharmaceutical
Former Vice President of Human Resources
2006
Josefina Elchico
La Jolla Pharmaceutical
Vice President of Quality Operations
2006
Michael Tansey
La Jolla Pharmaceutical